Report cover image

Remicade Market, By Indication (Crohns Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, and Plaque Psoriasis), By Patient Age Group (Adult, Pediatric, Geriatric), By Distribution Channel (Hospital Pharmacies,

Published Jun 17, 2025
Length 165 Pages
SKU # CMI20173667

Description

The Global Remicade Market is estimated to be valued at USD 1,422.0 Mn in 2025 and is expected to reach USD 655.0 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -10.48% from 2025 to 2032. Despite the prevalence of autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis, the Remicade market is on a decline. Although Remicade, a monoclonal antibody targeting tumor necrosis factor-alpha (TNF-α), has been effective in managing these conditions, the market faces several challenges. The high cost of treatment, emergence of biosimilars, and growing competition from alternative therapies have significantly limited the market's growth potential. As a result, the Remicade market is contracting, with growth prospects becoming increasingly limited in the coming years.

Market Dynamics

The global Remicade market is currently experiencing a decline, influenced by several key factors. While autoimmune diseases have historically supported demand for effective treatments, the market is now facing substantial hurdles. The high cost of Remicade treatment has restricted access to the drug, particularly in low- and middle-income regions. Additionally, the rise of biosimilars offering cheaper alternatives is eroding Remicade’s market share. Competition from newer therapies, as well as pricing pressures, are contributing to the market’s decline. As a result, despite ongoing efforts to expand indications and develop new formulations, the increasing competition and pricing challenges are severely limiting any potential for growth in the market.

Key Features of the Study
  • This report provides in-depth analysis of the global Remicade market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Remicade market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson Services, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Remicade market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Remicade market
Market Segmentation
  • Indication Insights (Revenue, USD Mn, 2020 - 2032)
  • Crohn’s Disease
  • Ulcerative Colitis
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Patient Age Group Insights (Revenue, USD Mn, 2020 - 2032)
  • Adult
  • Pediatric
  • Geriatric
  • Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Johnson & Johnson Services, Inc.

Table of Contents

165 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Remicade Market, By Indication
Global Remicade Market, By Patient Age Group
Global Remicade Market, By Distribution Channel
Global Remicade Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Industry Trends
Reimbursement Scenario
Epidemiology
Pricing Analysis
4. Global Remicade Market, By Indication, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Crohn’s Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Ulcerative Colitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Rheumatoid Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Ankylosing Spondylitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Psoriatic Arthritis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Plaque Psoriasis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Remicade Market, By Patient Age Group, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Remicade Market, By Distribution Channel, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Remicade Market, By Region, 2020 - 2032, Value (USD Mn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Johnson & Johnson Services, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on ‘Remicade Market' - Global forecast to 2032
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.